Bad Blood: Secrets and Lies in a Silicon Valley Startup

The whole insider account of the astounding ascent and startling fall of a multibillion-dollar business, as told by the award-winning reporter who broke the story first and stuck with it through threats and coercion from the CEO and her attorneys.

Theranos CEO and creator Elizabeth Holmes was compared to the female Steve Jobs in 2014 by many. She was a bright Stanford dropout whose firm "unicorn" claimed to transform the medical sector by creating a device that would make blood testing more quicker and simpler. With the support of financiers like Tim Draper and Larry Ellison, Theranos raised $9 billion via the sale of shares, valuing Holmes at an estimated $4.7 billion. There was just one issue: the technology was broken.

Holmes had been deceiving investors, FDA representatives, and even her own staff for years. Threats of legal action were made against Carreyrou and The Wall Street Journal when the latter began to investigate after receiving information from a former employee of Theranos. In late 2015, the publication published the first of many Theranos pieces, unfazed. The business had no value at the beginning of 2017, and Holmes was in danger of legal action from the government and her investors. This is the gripping account of the worst corporate deception since Enron, a tale of cautionary alarm set against the backdrop of Silicon Valley's audacious promises and gold-rush hysteria.